Diltiazem induces severe photodistributed hyperpigmentation: Case series, histoimmunopathology, management, and review of the literature

Archives of Dermatology

Volumn 142, Issue 2, 2006, Pages 206-210

  Saladi, Rao N ^a   Cohen, Steven R ^a   Phelps, Robert G ^a   Persaud, Andrea N ^a   Rudikoff, Donald ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; CD3 ANTIBODY; DILTIAZEM; SUNSCREEN;

ADULT; AGED; ARTICLE; CASE REPORT; CLOTHING; DERMIS; DISEASE SEVERITY; DRUG ABSORPTION; DRUG EFFECT; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERPIGMENTATION; HYPERTENSION; IMMUNOPATHOLOGY; LABORATORY TEST; MALE; MONONUCLEAR CELL; PATIENT; PIGMENTATION; PRIORITY JOURNAL; SEROLOGY; SKIN BIOPSY; SKIN INFILTRATE; SPECTROPHOTOMETRY; STAINING; SUNLIGHT PROTECTION;

AGED; AGED, 80 AND OVER; BIOPSY; CALCIUM CHANNEL BLOCKERS; DIAGNOSIS, DIFFERENTIAL; DILTIAZEM; FEMALE; HUMANS; HYPERPIGMENTATION; MALE; MIDDLE AGED; SKIN;

EID: 33244458251     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.142.2.206     Document Type: Article

References (28)

1. Stern R, Khalsa JH. Cutaneous adverse reactions associated with calcium channel blockers. Arch Intern Med. 1989;149:829-832.
2. Seggev JS, Lagstein Z. Photosensitivity skin reactions to calcium channel blockers. J Allergy Clin Immunol. 1996;97:852-855.
3. Wirebaugh SR, Geraets DR. Reports of erythematous macular skin eruptions associated with diltiazem therapy. DICP. 1990;24:1046-1049.
4. Taylor JW, Cleary JD, Atkinson RC. Stevens-Johnson syndrome associated with diltiazem. Clin Pharm. 1990;9:948-950.
5. Sheehan-Dare RA, Goodfield MJ. Severe cutaneous vasculitis induced by diltiazem [letter]. Br J Dermatol. 1988;119:134.
6. Knowles S, Gupta AK, Shear NH. The spectrum of cutaneous reactions associated with diltiazem: three cases and a review of the literature. J Am Acad Dermatol. 1998;38(2, pt 1):201-206.
7. Hashimoto M, Tanaka S, Horio T. Photosensitivity due to diltiazem hydrochloride. Acta Dermatol. 1979;74:181-186.
8. Young L, Shehade SA, Chalmers RJ. Cutaneous reactions to diltiazem [letter]. Clin Exp Dermatol. 1990;15:467.
9. Scherschun L, Lee MW, Lim HW. Diltiazem-associated photodistributed hyperpigmentation: a review of 4 cases. Arch Dermatol. 2001;137:179-182.
10. Chawla A, Goyal S. Diltiazem-induced hyperpigmentation in an African American woman [letter]. J Am Acad Dermatol. 2002;46:468-469.
11. Boyer M, Katta R, Markus R. Diltiazem-induced photodistributed hyperpigmentation. Dermatol Online J. 2003;9:10.
12. Kuykendall-Ivy T, Collier SL, Johnson SM. Diltiazem-induced hyperpigmentation. Cutis. 2004;73:239-240.
13. Moore DE. Drug-induced cutaneous photosensitivity: incidence, mechanism, prevention and management. Drug Saf. 2002;25:345-372.
14. Miller SA, Hamilton SL, Wester UG, Cyr WH. An analysis of UVA emissions from sunlamps and the potential importance for melanoma. Photochem Photobiol. 1998;68:63-70.
15. Morison WL. Clinical practice: photosensitivity. N Engl J Med. 2004;350:1111-1117.
16. Physicians' Desk Reference. 57th ed. Montvale, NJ: Thomson Healthcare Inc; 2003.
17. Dereure O. Drug-induced skin pigmentation: epidemiology, diagnosis and treatment. Am J Clin Dermatol. 2001;2:253-262.
18. Svensson CK, Cowen EW, Gaspari AA. Cutaneous drug reactions. Pharmacol Rev. 2001;53:357-379.
19. Blackshear JL, Randle HW. Reversibility of blue-gray cutaneous discoloration from amiodarone. Mayo Clin Proc. 1991;66:721-726.
20. Wolf ME, Richer S, Berk MA, Mosnaim AD. Cutaneous and ocular changes associated with the use of chlorpromazine. Int J Clin Pharmacol Ther Toxicol. 1993;31:365-367.
21. Narurkar V, Smoller BR, Hu CH, Bauer EA. Desipramine-induced blue-gray photosensitive pigmentation. Arch Dermatol. 1993;129:474-476.
22. Pepine M, Flowers FP, Ramos-Caro FA. Extensive cutaneous hyperpigmentation caused by minocycline. J Am Acad Dermatol. 1993;28(2, pt 2):292-295.
23. Shelley WB, Shelley ED, Burmeister V. Argyria: the intradermal "photograph," a manifestation of passive photosensitivity. J Am Acad Dermatol. 1987;16(1, pt 2):211-217.
24. Crowson AN, Magro CM. Diltiazem and subacute cutaneous lupus erythematosus-like lesions [letter]. N Engl J Med. 1995;333:1429.
25. Crowson AN, Magro CM. Subacute cutaneous lupus erythematosus arising in the setting of calcium channel blocker therapy. Hum Pathol. 1997;28:67-73.
26. Hammentgen R, Lutz G, Kohler U, Nitsch J. Maculopapular exanthema during diltiazem therapy [in German]. Dtsch Med Wochenschr. 1988;113:1283-1285.
27. Lambert DG, Dalac S, Beer F, Chavannet P, Portier H. Acute generalized exanthematous pustular dermatitis induced by diltiazem. Br J Dermatol. 1988;118:308-309.
28. Jones SK, Reynolds NJ, Crossley J, Kennedy CT. Cutaneous reaction to diltiazem resulting in an exacerbation of angina. Clin Exp Dermatol. 1989;14:457-458.